JST [JINPAN INTERNATIONAL] 6-K: (Original Filing)
[Dated: December 31, 2014 JINPAN INTERNATIONAL LIMITED]
NPD [China Nepstar Chain Drugstore] 6-K: China Nepstar Chain Drugstore Announces $5 Million Share
[China Nepstar Chain Drugstore Announces $5 Million Share Repurchase Program SHENZHEN, China, December 30, 2014 -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company’s Board of Directors has authorized a share repurchase program (the “Share Repurchase Program”).] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. th 6 Nanhai Road, Nanshan District. Shenzhen Guangdong Province 518054 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD.]
JST [JINPAN INTERNATIONAL] 6-K: Dated: December 31, 2014 JINPAN INTERNATIONAL LIMITED
[Dated: December 31, 2014 JINPAN INTERNATIONAL LIMITED]
SGOC [SGOCO] 6-K: (Original Filing)
[SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian) Electronic Co., Ltd Hong Kong, December 31, 2014 - SGOCO Group, Ltd. (Nasdaq: SGOC) (“SGOCO” or the “Company”), a company focused on product design, distribution and brand development in display products, today announced the sale of 100% of the equity of SGOCO (Fujian) Electronic Co., Ltd (“Sgoco Fujian”), a company registered in] []
TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)
[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]
SGOC [SGOCO] 6-K: SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian)
[SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian) Electronic Co., Ltd Hong Kong, December 31, 2014 - SGOCO Group, Ltd. (Nasdaq: SGOC) (“SGOCO” or the “Company”), a company focused on product design, distribution and brand development in display products, today announced the sale of 100% of the equity of SGOCO (Fujian) Electronic Co., Ltd (“Sgoco Fujian”), a company registered in] []
TPI [TIANYIN PHARMACEUTICAL] 10-Q:
[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]
